View Author
scopus: 34975070300

Farb, A.

(Andrew Farb)


plaque patient stent circulation university disease heart death thrombosis study trial factor event artery stent thrombosis cardiology medicine lesion assessment center syndrome blood artery disease registry research follow-up atherosclerosi department erasmus university rotterdam hospital atherosclerotic risk factors technique cardiol vulnerability infarction outcome ef ficacy coll cardiol school randomized development rupture drug-eluting inflammation intravascular marker imaging safety institute serruys pw table risk assessment strategies myocardium therapy drug-eluting stents noninvasive device naghavi future bare-metal stents result atherosclerotic plaques anti-platelet therapy association division treatment figure method resonance imaging 3 years protein laboratory fuster v culprit signi ficantly intravascular ultrasound group revascularization stenosi




3 Most Recent Publications

Meeting report: ESC forum on drug eluting stents European heart house, Nice, 27-28 September 2007 (Article)
Daemen, J. Simoons, M.L. Fajadet, J. Gitt, A.K. Guagliumi, G. Hillege, H.L. James, S.K. Jùni, P. Kastrati, A. Kloth, S. Kristensen, S.D. Krucoff, M. Wijns, W. Legrand, V.M.G. Pfisterer, M.E. Rothman, M. Serruys, P.W.J.C. Silber, S. Steg, P.G. Tariah, I. Wallentin, L.C. Windecker, S. Aimonetti, A. Bagust, A. Allocco, D. Baczynska, A. Berenger, M. Boam, A. Calle, J.P. Campo, G. Carlier, S.G. Schepper, J. de Bisceglie, G. di Dobbels, H. Bos, G. Farb, A. Ghislain, J.C. Hellbardt, S. Hoedt, R. ten Isaia, C. Jong, P. de Klasen, E. Lekehal, M. LeNarz, L. Ni Mhullain, F. Bowen, J.M. Nagai, H. Patteet, A. Paunovic, D. Potgieter, A. Purdy, I. Raveau-Landon, C. Ternstrom, S. Wuytswinkel, J. van Waliszewski, M. Braunwald, E. Camenzind, E. Chevalier, B. DiMario, C.
2009-01-01
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. (Article)
Naghavi, M. Libby, P. Fayad, Z. Stone, P.H. Waxman, S. Raggi, P. Madjid, M. Zarrabi, A. Burke, A.E. Yuan, C. Fitzgerald, P.J. Siscovick, D.S. Falk, E. Korte, C.L. de Aikawa, M. Juhani Airaksinen, K.E. Assmann, G. Becker, C.R. Chesebro, J.H. Farb, A. Galis, Z.S. Jackson, C. Jang, I.K. Casscells, S.W. Koenig, W. Lodder, R.A. March, K. Demirovic, J. Navab, M. Priori, S.G. Rekhter, M.D. Bahr, R. Grundy, S.M. Mehran, R. Litovsky, S. Colombo, A. Boerwinkle, E. Ballantyne, C. Insull Jr, W. Schwartz, R.S. Vogel, R. Serruys, P.W.J.C. Hansson, G.K. Faxon, D.P. Kaul, S. Rumberger, J. Drexler, H. Greenland, P. Muller, J.E. Virmani, R. Ridker, P.M. Zipes, D.P. Shah, P.K. Willerson, J.T. Badimon, J.J. Stefanadis, C. Moreno, P.R. Pasterkamp, G.
2003-10-14
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. (Article)
Naghavi, M. Libby, P. Fayad, Z. Stone, P.H. Waxman, S. Raggi, P. Madjid, M. Zarrabi, A. Burke, A.E. Yuan, C. Fitzgerald, P.J. Siscovick, D.S. Falk, E. Korte, C.L. de Aikawa, M. Juhani Airaksinen, K.E. Assmann, G. Becker, C.R. Chesebro, J.H. Farb, A. Galis, Z.S. Jackson, C. Jang, I.K. Casscells, S.W. Koenig, W. Lodder, R.A. March, K. Demirovic, J. Navab, M. Priori, S.G. Rekhter, M.D. Bahr, R. Grundy, S.M. Mehran, R. Litovsky, S. Colombo, A. Boerwinkle, E. Ballantyne, C. Insull Jr, W. Schwartz, R.S. Vogel, R. Serruys, P.W.J.C. Hansson, G.K. Faxon, D.P. Kaul, S. Rumberger, J. Drexler, H. Greenland, P. Muller, J.E. Virmani, R. Ridker, P.M. Zipes, D.P. Shah, P.K. Willerson, J.T. Badimon, J.J. Stefanadis, C. Moreno, P.R. Pasterkamp, G.
2003-10-07